Germany
Japan
United Kingdom
China
FCGR2B (Myc-DDK-tagged)-Human Fc fragment of IgG, low affinity IIb, receptor (CD32) (FCGR2B), transcript variant 4
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
Fluorescent Protein Antibodies
FCGR2B (Myc-DDK-tagged)-Human Fc fragment of IgG, low affinity IIb, receptor (CD32) (FCGR2B), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
CD3EAP (Myc-DDK-tagged)-Human CD3e molecule, epsilon associated protein (CD3EAP)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
IL5RA (Myc-DDK-tagged)-Human interleukin 5 receptor, alpha (IL5RA), transcript variant 6
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
MME (Myc-DDK-tagged)-Human membrane metallo-endopeptidase (MME), transcript variant 1bis
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
MME (Myc-DDK-tagged)-Human membrane metallo-endopeptidase (MME), transcript variant 2b
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
CD55 (Myc-DDK-tagged)-Human CD55 molecule, decay accelerating factor for complement (Cromer blood group) (CD55), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
CD33 (Myc-DDK-tagged)-Human CD33 molecule (CD33), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
KIT (GFP-tagged) - Human v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (KIT), transcript variant 1
| Vector | pCMV6-AC-GFP |
| Tag | TurboGFP |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
CD38 (untagged)-Human CD38 molecule (CD38)
| Vector | pCMV6-AC |
| Tag | Tag Free |
| Mammalian Cell Selection | Neomycin |
MME (Myc-DDK-tagged)-Human membrane metallo-endopeptidase (MME), transcript variant 2a
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
FCGR2C (Myc-DDK-tagged)-Human Fc fragment of IgG, low affinity IIc, receptor for (CD32) (FCGR2C), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
KLRD1 (Myc-DDK-tagged)-Human killer cell lectin-like receptor subfamily D, member 1 (KLRD1), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
FCGR2C (Myc-DDK-tagged)-Human Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene) (FCGR2C)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
FCGR2B (Myc-DDK-tagged)-Human Fc fragment of IgG, low affinity IIb, receptor (CD32) (FCGR2B), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
IL5RA (Myc-DDK-tagged)-Human interleukin 5 receptor, alpha (IL5RA), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
GP9 (Myc-DDK-tagged)-Human glycoprotein IX (platelet) (GP9)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
SIGLEC6 (Myc-DDK-tagged)-Human sialic acid binding Ig-like lectin 6 (SIGLEC6), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
CD34 (Myc-DDK-tagged)-Human CD34 molecule (CD34), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
CD68 (Myc-DDK-tagged)-Human CD68 molecule (CD68), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
ITGA3 (Myc-DDK-tagged)-Human integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) (ITGA3), transcript variant b
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
IL5RA (Myc-DDK-tagged)-Human interleukin 5 receptor, alpha (IL5RA), transcript variant 5
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
PTPRCAP (Myc-DDK-tagged)-Human protein tyrosine phosphatase, receptor type, C-associated protein (PTPRCAP)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
KLRD1 (Myc-DDK-tagged)-Human killer cell lectin-like receptor subfamily D, member 1 (KLRD1), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
ITGB2 (Myc-DDK-tagged)-Human integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) (ITGB2), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
SIGLEC6 (Myc-DDK-tagged)-Human sialic acid binding Ig-like lectin 6 (SIGLEC6), transcript variant 6
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
SIGLEC6 (Myc-DDK-tagged)-Human sialic acid binding Ig-like lectin 6 (SIGLEC6), transcript variant 5
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
SIGLEC6 (Myc-DDK-tagged)-Human sialic acid binding Ig-like lectin 6 (SIGLEC6), transcript variant 4
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
FCGR2B (Myc-DDK-tagged)-Human Fc fragment of IgG, low affinity IIb, receptor (CD32) (FCGR2B), transcript variant 5
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
FCGR3B (Myc-DDK-tagged)-Human Fc fragment of IgG, low affinity IIIb, receptor (CD16b) (FCGR3B)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
CD3E mouse monoclonal antibody, clone MEM-92, Purified
| Applications | FC, FN, IP |
| Reactivities | Human |
MMP12 (Myc-DDK-tagged)-Human matrix metallopeptidase 12 (macrophage elastase) (MMP12)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
Ltbr (Myc-DDK-tagged) - Mouse lymphotoxin B receptor (Ltbr)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
CD33 (Myc-DDK-tagged)-Human CD33 molecule (CD33), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
CD44 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector
| Format | Retroviral plasmids |
| Vector | pGFP-V-RS |
| E. coli Selection | Kanamycin |
| Mammalian Cell Selection | Puromycin |
Cd247 (Myc-DDK-tagged) - Mouse CD247 antigen (Cd247), transcript variant zeta
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
Fcgr2b (Myc-DDK-tagged) - Mouse Fc receptor, IgG, low affinity IIb (Fcgr2b), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
FCGR2A (untagged)-Human Fc fragment of IgG, low affinity IIa, receptor (CD32) (FCGR2A), transcript variant 1
| Vector | PCMV6-Neo |
| Tag | Tag Free |
| Mammalian Cell Selection | Neomycin |
THY1 (Myc-DDK-tagged)-Human Thy-1 cell surface antigen (THY1)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
CD22 (Myc-DDK-tagged)-Human CD22 molecule (CD22), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
CD61 (ITGB3) mouse monoclonal antibody, clone VIPL2, Aff - Purified
| Applications | FC, IHC, WB |
| Reactivities | Human, Primate |
CD163 (GFP-tagged) - Human CD163 molecule (CD163), transcript variant 1
| Vector | pCMV6-AC-GFP |
| Tag | TurboGFP |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
CD33 (untagged)-Human CD33 molecule (CD33), transcript variant 1
| Vector | pCMV6-XL5 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
Cd44 (Myc-DDK-tagged) - Mouse CD44 antigen (Cd44), transcript variant 6
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
GYPA (Myc-DDK-tagged)-Human glycophorin A (MNS blood group) (GYPA)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
CD44 (Myc-DDK-tagged)-Human CD44 molecule (Indian blood group) (CD44), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
CD44 (Myc-DDK tagged) - Homo sapiens CD44 molecule (Indian blood group) (CD44), transcript variant 6
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
FLT3 (GFP-tagged) - Human fms-related tyrosine kinase 3 (FLT3)
| Vector | pCMV6-AC-GFP |
| Tag | TurboGFP |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
Filter by
Target Symbol
- CD44 (266)
- CD68 (202)
- PTPRC (196)
- CD33 (166)
- NCAM1 (163)
- KIT (161)
- CD19 (153)
- CD22 (142)
- CD34 (138)
- MME (138)
- CD163 (129)
- FCGR2B (119)
- CD38 (114)
- CD3E (112)
- CD247 (111)
- IL5RA (109)
- FCGR2A (104)
- FCGR3A (99)
- CD55 (92)
- ITGAM (85)
- CCR3 (81)
- CD7 (80)
- IL3RA (80)
- SIGLEC6 (80)
- ITGB2 (78)
- ITGB3 (74)
- KLRD1 (73)
- ITGA3 (65)
- FLT3 (64)
- ITGA5 (62)
- CD3D (59)
- ITGA4 (59)
- ITGA6 (55)
- CD3EAP (54)
- CD3G (53)
- ITGA2B (50)
- THY1 (50)
- PTPRCAP (49)
- GP1BA (44)
- GP9 (44)
- ITGAX (44)
- ITGA1 (42)
- LTBR (40)
- SIGLEC15 (40)
- GYPA (39)
- ITGA2 (39)
- CD163L1 (36)
- FCGR3B (35)
- SIGLEC5 (33)
- TARP (30)
- FCGR2C (29)
- C2CD3 (27)
- MMP12 (19)
- FCGR4 (16)
- CD55B (14)
- LANCL3 (14)
- LIN52 (14)
- FCGR3 (13)
- MICU2 (13)
- CD45 (5)
- INTEGRIN ALPHA 3 (5)
- SCART1 (5)
- CD16 (4)
- PIK3CD (4)
- SIGLECF (4)
- TMEM225 (4)
- CD10 (2)
- CD16 (FCGR3A) (2)
- FLJ22814 (2)
- ITGB7 (2)
- UQCC3 (2)
- AU020772 (1)
- C KIT (1)
- CALD1 (1)
- CD11B (1)
- CD11C (1)
- CD16B (1)
- CD18 (1)
- CD32 (1)
- CD32A (1)
- CD32B (1)
- CD41 (1)
- CD42A (1)
- CD42B (1)
- CD49B (1)
- CD56 (1)
- CD61 (1)
- CD90 (1)
- CD94 (1)
- CEP295 (1)
- EFHA1 (1)
- FCGR2 (1)
- FCGR3A3 (1)
- GLYCOPHORIN A (1)
- INTEGRIN ALPHA 1 (1)
- INTEGRIN ALPHA 4 (1)
- INTEGRIN ALPHA 5 (1)
- INTEGRIN ALPHA 6 (1)
- KIAA1109 (1)
- PAF49 (1)
Species
Reactivities
Applications
Antibody Hosts
Isotypes
Clonalities
Conjugates
Knockout (KO) Validation
Expression Hosts
Lentivirus
Tags
- Myc-DDK (743)
- mGFP (498)
- Tag Free (254)
- C-Myc/DDK (200)
- TurboGFP (196)
- C-MYC/DDK (91)
- His-tag (34)
- C-His (22)
- N-His (13)
- C-DDK/His (6)
- C-Human Fc and 6×His (4)
- C-Fc&His (3)
- DDK-His (3)
- C-6His (2)
- C-DDK (2)
- C-Fc (2)
- C-Fc/His (2)
- C-hFc&His (2)
- C- 6×His (1)
- C-6×His (1)
- C-His/DDK (1)
- C-Mouse Fc (1)
- N-GST (1)
Vectors
- pLenti-C-Myc-DDK-P2A-Puro (396)
- pCMV6-Entry (394)
- pLenti-C-mGFP-P2A-Puro (382)
- pGFP-C-shLenti (273)
- pCMV6-AC-GFP (196)
- pRS (143)
- pLenti-C-mGFP (116)
- EF1a-GFP-P2A-Puro (103)
- pLenti-C-Myc-DDK (93)
- pCMV6-XL5 (36)
- pCMV6-XL4 (30)
- pGFP-V-RS (20)
- PCMV6-Kan/Neo (12)
- pCMV6-AC (11)
- GFP-puro (10)
- Luciferase-Puro (10)
- RFP-BSD (10)
- mBFP-Neo (10)
- pRFP-C-RS (10)
- PCMV6-Neo (6)
- pCMV6-XL5-DDK-His (3)
- pCMV6-XL6 (3)
Reporters
Modifications
- Unmodified (45)
- Phospho-specific (16)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (12)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (12)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (4)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (3)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2b format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- Phospho Y589/591 (1)
- Phospho Y719 (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG2 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This constant region of this antibody has been modified to bind to Protein A, allowing highly-specific purification of this antibody by Protein A-affinity column. (1)
- This is a chimeric mouse antibody, based on the original hamster IgG format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This is a reformatted human IgG1 antibody based on the therapeutic Fab fragment. NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Assay Platforms
Disease States
Diagnosis
- Normal (459)
- Lung Cancer (208)
- Colorectal Cancer (201)
- Breast Cancer (151)
- Renal Cell Carcinoma (102)
- Ovarian Cancer (78)
- Lymphoma (71)
- Chronic Obstructive Pulmonary Disease (COPD) (65)
- Pneumonia (56)
- Prostate Cancer (39)
- Borderline Ovarian Tumor (35)
- Benign Prostatic Hyperplasia (BPH) (30)
- Fibrocystic Breast (28)
- Melanoma (27)
- Esophageal/Gastroesphageal Cancer (22)
- Prostatitis (19)
- Bladder Cancer (17)
- Fatty Changes To Liver (16)
- Liver Cancer (16)
- Nephritis (12)
- Prostatic Intraepithelial Neoplasia (PIN) (12)
- Fibrosis (10)
- Stomach Cancer (10)
- Cirrhosis (7)
- Hyperplasia (7)
- Hepatitis (6)
- Pancreatic Cancer (5)
- Endometrial Cancer (3)
- Adenosis of Breast (2)
- Benign Tumor (2)
- Mastitis (2)
- Proteinosis (2)
- Biopsy Site Changes (1)
- Cervicitis (1)
- Cystitis (1)
- Gastritis (1)
- Head and Neck Cancer (1)
- Inflammation (1)
- Pancreatitis (1)
- Sarcoidosis (1)
- Sarcoma (1)
- Sialadenitis (1)
- Thyroid Cancer (1)
Tissues
- Lung (465)
- Colon (291)
- Kidney (204)
- Breast (201)
- Ovary (122)
- Prostate (120)
- Lymphoid tissue (71)
- Liver (70)
- Skin (27)
- Stomach (24)
- Esophagus (22)
- Urinary bladder (19)
- Small intestine (16)
- Spleen (14)
- Uterus (14)
- Pancreas (13)
- Gastroesophageal junction (7)
- Lymph node (6)
- Parotid gland (4)
- Endometrium (3)
- Myometrium (3)
- Bile duct (2)
- Cervix (2)
- Testis (2)
- Epiglottis (1)
- Fallopian tube (1)
- Muscle tissue (1)
- Omentum (1)
- Salivary gland (1)
- Smooth muscle (1)
- Thyroid gland (1)
- Tonsil (1)
- Ureter (1)
Mammalian Cell Selection
Families
- Transmembrane (2400)
- Druggable Genome (2057)
- ES Cell Differentiation/IPS (1135)
- Adult stem cells (365)
- Embryonic stem cells (365)
- Cancer stem cells (299)
- Secreted Protein (246)
- Stem cell relevant signaling - DSL/Notch pathway (167)
- Phosphatase (149)
- Protein Kinase (140)
- Stem cell - Pluripotency (111)
- Protease (101)
- GPCR (45)
- Induced pluripotent stem cells (45)
- Transcription Factors (16)
Pathways
- Hematopoietic cell lineage (1390)
- Cell adhesion molecules (CAMs) (544)
- Fc gamma R-mediated phagocytosis (380)
- ECM-receptor interaction (375)
- Primary immunodeficiency (313)
- Cytokine-cytokine receptor interaction (301)
- Regulation of actin cytoskeleton (273)
- Systemic lupus erythematosus (271)
- B cell receptor signaling pathway (264)
- T cell receptor signaling pathway (261)
- Pathways in cancer (231)
- Natural killer cell mediated cytotoxicity (216)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (177)
- Dilated cardiomyopathy (177)
- Focal adhesion (177)
- Hypertrophic cardiomyopathy (HCM) (177)
- Lysosome (154)
- Acute myeloid leukemia (140)
- Endocytosis (111)
- Melanogenesis (111)
- Leukocyte transendothelial migration (107)
- Prion diseases (106)
- Jak-STAT signaling pathway (105)
- Alzheimer's disease (97)
- Renin-angiotensin system (97)
- Small cell lung cancer (91)
- Viral myocarditis (80)
- Calcium signaling pathway (45)
- Chemokine signaling pathway (45)
- Metabolic pathways (45)
- Nicotinate and nicotinamide metabolism (45)
- Complement and coagulation cascades (43)
- Antigen processing and presentation (42)
- Graft-versus-host disease (42)
- Apoptosis (40)
- Vascular smooth muscle contraction (1)